Back to top
Read MoreHide Full Article

Allergan Inc. ((AGN - Free Report) ) was a big mover last session, as the company saw its shares surge over 15.0% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 30.8% in the past one-month time frame.

In the last 30 days, this company witnessed 1 upward estimate revision, while the Zacks Consensus Estimate remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Allergan currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Other players in the healthcare industry include Myriad Genetics Inc. (MYGN - Free Report) , ANI Pharmaceuticals, Inc. (ANIP - Free Report) and Aastrom Biosciences, Inc. all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALLERGAN INC (AGN - Free Report) : Free Stock Analysis Report

MYRIAD GENETICS INC (MYGN - Free Report) : Free Stock Analysis Report

AASTROM BIOSCIENCES INC : Free Stock Analysis Report

ANI PHARMACEUTICALS INC (ANIP - Free Report) : Free Stock Analysis Report

Zacks Investment Research

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Allergan PLC. (AGN) - free report >>

Myriad Genetics, Inc. (MYGN) - free report >>

ANI Pharmaceuticals, Inc. (ANIP) - free report >>

More from Zacks Tale of the Tape

You May Like